These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3980330)

  • 1. Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection.
    Zak O; Tosch W; Sande MA
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():273-82. PubMed ID: 3980330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among antibiotics, bacteria and the human immune system: the clinical relevance of in vitro testing.
    Bergogne-Berezin E
    J Chemother; 1997 May; 9 Suppl 1():109-15. PubMed ID: 9248969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitions of antibacterial interactions in animal infection models.
    Renneberg J
    J Antimicrob Chemother; 1993 May; 31 Suppl D():167-75. PubMed ID: 8335518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 6. A new tolypomycin-Y derivative: in vitro and in vivo antimicrobial activity.
    Stanzani L; Venturini AP; Mantovani V
    J Antibiot (Tokyo); 1978 Nov; 31(11):1195-200. PubMed ID: 721713
    [No Abstract]   [Full Text] [Related]  

  • 7. The post-antibiotic sub-MIC effect in vitro and in vivo.
    Cars O; Odenholt-Tornqvist I
    J Antimicrob Chemother; 1993 May; 31 Suppl D():159-66. PubMed ID: 8335517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.
    Liu P; Rand KH; Obermann B; Derendorf H
    Int J Antimicrob Agents; 2005 Feb; 25(2):120-9. PubMed ID: 15664481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical relevance of low concentrations of antibiotics.
    Lorian V
    J Antimicrob Chemother; 1993 May; 31 Suppl D():137-48. PubMed ID: 8335515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model.
    Katsube T; Yamano Y; Yano Y
    J Pharm Sci; 2008 Apr; 97(4):1606-14. PubMed ID: 17705288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.
    Li M; Neoh KG; Xu L; Yuan L; Leong DT; Kang ET; Chua KL; Hsu LY
    Pharm Res; 2016 May; 33(5):1161-74. PubMed ID: 26792570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of heneicomycin.
    Frost BM; Valiant ME; Dulaney EL
    J Antibiot (Tokyo); 1979 Jun; 32(6):626-9. PubMed ID: 468738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antibacterial activities of clarithromycin.
    Ono T; Numata K; Nagate T; Mitsuhashi S; Inoue M
    Chemotherapy; 1996; 42(3):159-69. PubMed ID: 8983882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is a repeat treatment of antibiotic therapy necessary?].
    Seeger K
    Tierarztl Prax; 1988; 16(2):109-12. PubMed ID: 3047908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro MIC break point for appropriate clinical use of antibiotic].
    Uete T; Matsuo K
    Jpn J Antibiot; 1993 Mar; 46(3):205-21. PubMed ID: 8510318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy and pharmacodynamics in the management of bacterial infection.
    Rotschafer JC; Zabinski RA; Walker KJ; Vance-Bryan K
    J Clin Pharmacol; 1992 Dec; 32(12):1083-8. PubMed ID: 1487545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.
    Zhao M; Lepak AJ; Andes DR
    Bioorg Med Chem; 2016 Dec; 24(24):6390-6400. PubMed ID: 27887963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.